Virtu Financial LLC Trevena Inc Transaction History

Virtu Financial LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.16 - $100.0 $19,558 - $12.2 Million	122,242 Added 72.66%	290,480 $45,000
Q2 2022 Aug 09, 2022	BUY	$0.2 - $0.5 $33,647 - $84,119	168,238 New	168,238 $70,000
Q1 2022 May 17, 2022	SELL	$0.41 - $0.63 $73,644 - $113,161	-179,621 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.57 - $1.29 $102,383 - $231,711	179,621 New	179,621 $105,000
Q3 2021 Nov 12, 2021	SELL	$1.11 - $1.7 $162,236 - $248,470	-146,159 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$1.46 - $2.25 $213,392 - $328,857	146,159 New	146,159 $247,000
Q1 2021 May 19, 2021	SELL	$1.77 - $2.93 $34,769 - $57,556	-19,644 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$2.13 - $3.26 $219,581 - $336,073	-103,090 Reduced 83.99%	19,644 $42,000
Q3 2020 Dec 11, 2020	BUY	$1.53 - $3.13 $74,373 - $152,149	48,610 Added 65.58%	122,734 $367,000
Q2 2020 Aug 07, 2020	BUY	$0.48 - $1.75 $35,579 - $129,717	74,124 New	74,124 $111,000
Q3 2019 Nov 20, 2019	SELL	$0.81 - $1.06 $36,112 - $47,257	-44,583 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$0.94 - $1.6 $22,622 - $38,505	24,066 Added 117.3%	44,583 $46,000
Q1 2019 Apr 12, 2019	SELL	$0.51 - $1.88 $86,653 - $319,427	-169,908 Reduced 89.23%	20,517 $32,000
Q4 2018 Jan 16, 2019	BUY	$0.39 - $3.47 $74,265 - $660,774	190,425 New	190,425 $82,000
Q1 2018 May 14, 2018	SELL	$1.51 - $2.06 $289,468 - $394,904	-191,701 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$1.4 - $2.6 $252,076 - $468,143	180,055 Added 1546.07%	191,701 $307,000
Q3 2017 Nov 15, 2017	BUY	$2.22 - $2.79 $25,854 - $32,492	11,646	11,646 $0

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.